Fig. 6From: Antidiabetic potential of Lysiphyllum strychnifolium (Craib) A. Schmitz compounds in human intestinal epithelial Caco-2 cells and molecular docking-based approachesThe proposed mechanisms by which 3,5,7-trihydroxychromone-3-O-α-L-rhamnopyranoside (compound 1) and 3,5,7,3’,5’-pentahydroxy-flavanonol-3-O-𝛼-L-rhamnopyranoside (compound 2) inhibit glucose catalysis in enterocytes of the small intestine and their effect on the glucose transporter SGLT1, GLUT2, and GLUT5Back to article page